Canadian Institutes of Health Research
570,556 snapshots · latest May 3, 2026
Homepage:https://cihr-irsc.gc.ca/
Archive explorer
Browse & search snapshots
Important note
Browse and search historical snapshots. This is an archive — not current guidance or medical advice. Archived content may be incomplete, outdated, or superseded. For up-to-date recommendations, always consult the official source website.
For background on coverage and capture methods, see Methods & coverage.
Browse archived sites
Health Canada
386,223 snapshots · latest Apr 14, 2026
Public Health Agency of Canada
243,880 snapshots · latest Apr 28, 2026
Clinical Trials Manual This manual is based on Health Canada's Guidance for Clinical Trial Sponsors: Clinical Trial Applications and other applicable guidance documents. It is designed to provide tools and relevant links in order to facilitate the successful filing of a Clinical…
Guidance on expanded access clinical trials: Overview Overview Information for potential participants Information for sponsors and health care providers Contact information Glossary Download in PDF format (808 KB, 31 pages) Organization: Health Canada Published: 2025-09-29 Cat.:…
Chemical Entity Products/Quality Guidance Document: Quality (Chemistry and Manufacturing): New Drug Submissions (NDSs) and Abbreviated New Drug Submissions (ANDSs) [2024-12-18] Guidance Document: Addendum - Quality (Chemistry and Manufacturing) Guidance: Questions and Answers…
Guidance Document: Use of a Foreign-sourced Reference Product as a Canadian Reference Product Download the alternative format (PDF format, 264 KB, 14 pages) Foreword Guidance documents are meant to provide assistance to industry and health care professionals on how to comply with…
Guidance for industry on safety monitoring and reporting requirements for marketed biocides: Overview Overview Safety monitoring Serious incident reporting Issue-related reports Information retention requirements Definitions Download in PDF format (593 KB, 28 pages) Organization:…
Draft Guidance for Industry: Preparation of Comparative Bioavailability Information for Drug Submissions in the CTD Format (PDF Version - 91 K) Contact: Bureau of Pharmaceutical Sciences (BPS) Enquiries Draft Guidance For Industry Preparation of Comparative Bioavailability…
Final Guidance Document Data Requirements for Safety and Effectiveness of Steroid Nasal Products for Use in the Treatment of Allergic Rhinitis for Industry (PDF Version - 118 K) Contact: Bureau of Cardiology, Allergy and Neurological Sciences (BCANS) September 19, 2011 Notice Our…
Guidance Document - Comparative Bioavailability Standards: Formulations Used for Systemic Effects (PDF Version - 319 K) Date Adopted: 2012/12/08 Revised Date: 2018/06/08 Effective Date: 2018/09/01 (for submissions filed on or after September 1, 2018) Please refer to the Notice to…
Comparative Pharmacokinetic Studies for Orally Inhaled Products: Guidance Document ( PDF version , 250 KB) Date adopted: December 21, 2020 Date posted: December 21, 2020 Effective date: December 21, 2020 On this page Introduction Policy objectives Policy statement Scope and…
Notice: Guidance Document - Data Requirements for Safety and Effectiveness of Subsequent Entry Inhaled Corticosteroid Products Used for the Treatment of Asthma October 31, 2018 Our file number: 18-111871-354 Health Canada is pleased to announce the release of the Guidance…
Early release: coverage and features are still expanding.
